SCHEMBL19959875

SCHEMBL19959875

O=P(c1ccccc1)(c1cnc2ccccc2c1)c1ccc2nc3c4ccccc4c4ccccc4n3c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.37
MAPT P10636 4/20 0.37
TP53 P04637 2/20 0.37
HSD17B10 Q99714 2/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 5/20 0.36
HPGD P15428 5/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
KDR P35968 1/20 0.34
AHR P35869 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
TOP2A P11388 1/20 0.33
TOP2B Q02880 1/20 0.33
MGAM O43451 1/20 0.33
UTRN P46939 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19959921 0.94 KDM4E (0.35) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19959888 0.94 KDM4E (0.38) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19959896 0.93 KDM4E (0.39) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19959783 0.90 KDM4E (0.38) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19960165 0.90 KDM4E (0.37) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19928976 0.89 KDM4E (0.42) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19959938 0.88 KDM4E (0.36) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19959944 0.87 KDM4E (0.37) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19959874 0.87 KDM4E (0.37) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19928996 0.86 AHR (0.39) KDM4EMAPTTP53HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885TP53 3534/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885TP53 3534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.